CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Alendronate sodium/cholecalciferol

Last Updated: March 27, 2006
Result type: Reports
Project Number: SR0059-000
Product Line: Reimbursement Review

Generic Name: Alendronate sodium/cholecalciferol

Brand Name: Fosavance

Manufacturer: Merck Frosst Canda Ltd.

Therapeutic Area: Osteoporosis

Indications: Osteoporosis

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: September 27, 2006

Recommendation Type: Do not list